When I last wrote about the US "Big Pharma" concern Amgen (NASDAQ:AMGN) for Seeking Alpha just over one month ago I gave the company a bullish rating, noting that shares were trading at a ~23% ...

Amgen Inc. on Thursday said it would lay off about 450 employees, or less than 2% of its workforce, as it faces increasing pressure from drug prices and high inflation. “We made these changes to ...

Amgen's new research and development facility in San Francisco. (courtesy photo) For the second time this year, Amgen is ...

Amgen, a drugmaker based in Thousand Oaks, Calif., will lay off 450 people — 2 percent of its workforce — with many separations occurring by May 26, according to a statement shared with Becker's. "We ...

In January, Amgen laid off about 300 employees as part of organizational changes, which "mainly" impacted the U.S.-based commercial team. "We made these changes to better manage against industry ...

US biotechnology firm Amgen said it would cut nearly 450 jobs, or less than 2% of its workforce. The company cited pressure ...

Amgen Inc. announced on Thursday that it would eliminate 450 positions, or less than 2% of its staff, marking the company's ...

Amgen is laying off about 450 workers, the company told Endpoints News, just two months after letting go 300 staffers. A spokesperson said the layoffs impact less than 2% of the California biopharma's ...

(Reuters) -Amgen Inc said on Thursday it would cut 450 jobs, or less than 2% of its workforce, making it the company's second round of layoffs this year amid intensifying pressure on drug prices ...